NCT06304272

Brief Summary

There is a controversy regarding the roles of the Normal saline and Tap water in irrigation of the wound. It has been suggested that antiseptic solution including normal saline has cytotoxic effect while tap water damages the fibroblast. There are no high level evidence to support one type of solution over other, systematic review have found no difference in wound infection between irrigation with normal saline vs tap water. There are ten randomized controlled trial comparing tap water with normal saline for irrigating wound published between 1992 to 2016. These RCT are analyzed in three systemic review and meta-analysis published on 2016, 2019, 2022, which showed that tap water and normal saline has no difference in terms of infection rate. The infection rate observed in various studies ranges from 0-11.5% in normal saline group and 0-12.6% in tap water group with no statistically significant difference.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
440

participants targeted

Target at P75+ for not_applicable

Timeline
19mo left

Started Mar 2024

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Mar 2024Dec 2027

First Submitted

Initial submission to the registry

February 20, 2024

Completed
10 days until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 12, 2024

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

March 12, 2024

Status Verified

March 1, 2024

Enrollment Period

2.5 years

First QC Date

February 20, 2024

Last Update Submit

March 4, 2024

Conditions

Keywords

Traumatic WoundWound Infection

Outcome Measures

Primary Outcomes (1)

  • Comparison between drinking water and normal saline in irrigating traumatic wound: Noninferiority trial.

    Difference in wound infection rates between the two randomized groups. Wound evaluation was based on the following criteria No infection: 1. No discharge or fever on day 3 2. Dry and no fever on day 7 Infection 1\. Fever greater than 1000 F or pus discharge on any day 2. Erythema with serous discharge on any day

    3-7 Days

Study Arms (2)

Irrigating Traumatic Wound with Drinking Water

EXPERIMENTAL

In drinking water arm, acute traumatic wound will be cleaned with drinking water. Bacteriological safety of the drinking water will be ensured by testing water.

Procedure: Irrigating Traumatic Wound with Drinking Water

Irrigating Traumatic Wound with Normal Saline

EXPERIMENTAL

In normal saline arm, acute traumatic wound will be cleaned with normal saline.

Procedure: Irrigating Traumatic Wound with Drinking Water

Interventions

Irrigating Traumatic Wound with Drinking Water and Normal Saline

Also known as: Irrigating Traumatic Wound with Normal Saline
Irrigating Traumatic Wound with Drinking WaterIrrigating Traumatic Wound with Normal Saline

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Laceration wound presenting within 6 hours of duration
  • Lacerations involving upper and lower limbs, scalps, head and neck

You may not qualify if:

  • Lacerations involving, lips, ears, mucosal surface, perineal and peri anal region
  • Punctured or penetrating wound
  • Bite wounds by human or animals or snakes
  • Dirty wound requiring surgical debridement
  • Patient requiring irrigation of wound with more than 1 liter of fluid
  • Wounds involving tendon, joint or bone
  • Wound associated with open fracture
  • Patient on corticosteroid, antibiotics or immunosuppressant
  • Patient who are not able to come for follow-up
  • Immunocompromised patient
  • Patient with history of significant peripheral vascular disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Wounds and InjuriesWound Infection

Interventions

Drinking WaterSaline Solution

Condition Hierarchy (Ancestors)

Infections

Intervention Hierarchy (Ancestors)

WaterHydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen CompoundsBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Ashis Shrestha, Fellow

    Patan Academy of Health Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ashis Shrestha, Fellow

CONTACT

Sumana Bajracharya, Fellow

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized, double blinded, parallel, non-inferiority trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 20, 2024

First Posted

March 12, 2024

Study Start

March 1, 2024

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

March 12, 2024

Record last verified: 2024-03